Capron, C., Martin Morales, L., & Rapino, F. (17 May 2023). Novel bioinformatics mRNA translation multi-omics analysis identifies key features of the intestinal cancer stem cells [Poster presentation]. Gordon Research Conference - Stem Cells and Cancer, Lucca, Italy. |
Martin Morales, L., Capron, C., & Rapino, F. (14 May 2023). Unveiling the role of tRNA modifications in the establishment of intestinal Cancer Stem Cells [Poster presentation]. Stem Cells and Cancer GRC: Strategies for Controlling Development, Tissue Homeostasis and Cancer, Lucca, Italy. |
Martin Morales, L.* , Manzano, S.* , Rodrigo-Faus, M.* , Vicente-Barrueco, A., Lorca, V., Núñez-Moreno, G., Bragado, P., Porras, A., Caldes, T., Garre, P., & Gutierrez-Uzquiza, A. (January 2023). Germline gain-of-function MMP11 variant results in an aggressive form of colorectal cancer. International Journal of Cancer, 152 (2), 283-297. doi:10.1002/ijc.34289 * These authors have contributed equally to this work. |
Martin Morales, L., Capron, C., & Rapino, F. (12 June 2022). Translation-dependent establishment of intestinal Cancer Stem Cells [Poster presentation]. 28th tRNA Conference, Columbus, United States - Ohio. |
Martin Morales, L., Capron, C., & Rapino, F. (13 May 2022). Translation-dependent establishment of intestinal Cancer Stem Cells [Poster presentation]. 7th Annual Meeting of the Belgian Society for Stem Cell Research, Liège, Belgium. |
Martin Morales, L., Garre, P., Lorca, V., Cazorla, M., Llovet, P., Bando, I., Garcia-Barberan, V., Gonzalez-Morales, M. L., Esteban-Jurado, C., de la Hoya, M., Castellvi-Bel, S., & Caldes, T. (February 2021). BRIP1, a Gene Potentially Implicated in Familial Colorectal Cancer Type X. Cancer Prevention Research, 14 (2), 185-194. doi:10.1158/1940-6207.CAPR-20-0316 |
Martin Morales, L. (2019). Searching for New Genes Involved in Familial Colorectal Cancer Type X by Whole-Exome Sequencing [Doctoral thesis, Complutense University of Madrid]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/260351 |
Lorca, V., Rueda, D., Martin Morales, L., Fernandez-Aceñero, M. J., Grolleman, J., Poves, C., Llovet, P., Tapial, S., Garcia-Barberan, V., Sanz, J., Perez-Segura, P., de Voer, R. M., Diaz-Rubio, E., de la Hoya, M., Caldes, T., & Garre, P. (July 2019). Contribution of New Adenomatous Polyposis Predisposition Genes in an Unexplained Attenuated Spanish Cohort by Multigene Panel Testing. Scientific Reports, 9 (1), 9814. doi:10.1038/s41598-019-46403-5 |
Martin Morales, L., Fledman, M., Vershinin, Z., Garre, P., Levy, D., & Caldes, T. (19 November 2018). SETD6 dominant negative mutation in Familial Colorectal Cancer Type X [Poster presentation]. I CIBERONC Young Researchers Meeting, Madrid, Spain. |
Martin Morales, L. (2018). AECC in research, a constant and stable support for quality research [Paper presentation]. World Cancer Research Day, Madrid, Spain. |
Martin Morales, L.* , Rofes, P.* , Diaz-Rubio, E., Llovet, P., Lorca, V., Bando, I., Perez-Segura, P., de la Hoya, M., Garre, P., Garcia-Barberan, V., & Caldes, T. (September 2018). Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition. PLoS ONE, 13 (9), 0203885. doi:10.1371/journal.pone.0203885 * These authors have contributed equally to this work. |
Martin Morales, L., Feldman, M., Vershinin, Z., Garre, P., Levy, D., & Caldes, T. (14 November 2017). SETD6 dominant negative mutation in Familial Colorectal Cancer Type X [Poster presentation]. 1st ASEICA Educational Symposium, Madrid, Spain. |
Lorca, V., Rueda, D., Martin Morales, L., Poves, C., Fernandez-Aceñero, M. J., Ruiz-Ponte, C., Llovet, P., Marrupe, D., Garcia-Barberan, V., Garcia-Paredes, B., Perez-Segura, P., de la Hoya, M., Diaz-Rubio, Caldes, T., & Garre, P. (November 2017). Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome. PLoS ONE, 12 (11), 0187312. doi:10.1371/journal.pone.0187312 |
Martin Morales, L., Feldman, M., Vershinin, Z., Garre, P., Caldes, T., & Levy, D. (November 2017). SETD6 dominant negative mutation in familial colorectal cancer type X. Human Molecular Genetics, 26 (22), 4481-4493. doi:10.1093/hmg/ddx336 |
Llovet, P., Illana, F., Martin Morales, L., de la Hoya, M., Garre, P., Ibañez-Royo, M. D., Perez-Segura, P., Caldes, T., & Garcia-Barberan, V. (October 2017). A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families. Familial Cancer, 16 (4), 567-575. doi:10.1007/s10689-017-9990-0 |
Martin Morales, L., Tosar, A., Delgado, J., Rofes, P., Lorca, V., de la Hoya, M., Bienz, M., Levy, D., Garre, P., & Caldes, T. (05 July 2017). Exome sequencing approach for the identification of high-risk genetic variants in FCC-X families [Poster presentation]. 2017 InSiGHT biennial meeting, Florence, Italy. |
Martin Morales, L. (2017). Whole-exome sequencing approach for the identification of high-risk genetic variants in FCC-X families [Paper presentation]. Management Committee and Working Groups Joint Meeting organized by COST Action BM1206 “Cooperation studies on inherited susceptibility to colorectal cancer”, Porto, Portugal. |
Martin Morales, L., Tosar, A., Delgado, J., Rofes, P., Lorca, V., de la Hoya, M., Bienz, M., Levy, D., Garre, P., & Caldes, T. (08 February 2017). Whole-exome sequencing approach for the identification of high-risk genetic variants in FCC-X families [Poster presentation]. Management Committee and Working Groups Joint Meeting organized by COST Action BM1206 “Cooperation studies on inherited susceptibility to colorectal cancer”, Porto, Portugal. |
Martin Morales, L., Bailen, C., Tosar, A., de la Hoya, M., Perez-Segura, P., Garre, P., & Caldes, T. (19 May 2016). Analysis of germline exome sequencing data in 32 patients from 13 FCC-X families [Poster presentation]. ESO, CNIO and NRCO Conference on Familial Cancer, Madrid, Spain. |
Martin Morales, L. (2016). Analysis of germline exome sequencing data in 32 colorectal cancer patients from 13 Amsterdam I/II HNPCC proficient families [Paper presentation]. Management Committee and Working Groups Joint Meeting organized by COST Action BM1206 “Cooperation studies on inherited susceptibility to colorectal cancer”, Prague, Czechia. |
Garre, P., Martin Morales, L., Sanz, J., Romero, A., Tosar, A., Bando, I., Llovet, P., Diaque, P., Garcia-Paredes, B., Diaz-Rubio, E., de la Hoya, M., & Caldes, T. (June 2015). BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X. Clinical Genetics, 87 (6), 582-7. doi:10.1111/cge.12427 |
Garre, P., Martin Morales, L., Bando, I., Tosar, A., Llovet, P., Sanz, J., Romero, A., de la Hoya, M., Diaz-Rubio, E., & Caldes, T. (March 2014). Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer. Familial Cancer, 13 (1), 109-19. doi:10.1007/s10689-013-9683-2 |
Garre, P., Martin Morales, L., Tosar, A., Llovet, P., Romero, A., Bando, I., de la Hoya, M., Perez-Segura, P., Diaz-Rubio, E., & Caldes, T. (14 March 2013). Repair genes XRCC1, PCNA, RAD51C, RAD51D and SLX4 in Hereditary Non-Polyposis Colorectal Cancer without mismatch repair deficiency (MSS-HNPCC) [Poster presentation]. IV Annual IMPPCC Conference/1st ICO-IDIBELL Hereditary Cancer Program Meeting, Barcelona, Spain. |
Martin Morales, L. (2012). Study of the XRCC1 and PCNA genes from the BER pathway in families with Hereditary Microsatellite-Stable Non-Polyposis Colorectal Cancer (HNPCC-MSS) [Master’s dissertation, Complutense University of Madrid]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/260388 |
Martin Morales, L., Garre, P., Romero, A., de la Hoya, M., & Caldes, T. (07 June 2012). BER Pathway in Familial Colorectal Cancer Type-X [Poster presentation]. 5th ESO/CNIO Familial Cancer Conference, Madrid, Spain. |
Martin Morales, L. (2011). Folate Receptor α as an antibody target to prevent the folic acid-dependent activation of the STAT3 oncogene [Master’s dissertation, AU - Aarhus Universitet]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/260421 |